Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 1
2016 2
2017 12
2018 6
2019 4
2020 6
2021 8
2022 9
2023 10
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Pathological autoantibody internalisation in myositis.
Pinal-Fernandez I, Muñoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J, Dell'Orso S, Naz F, Islam S, Gutierrez-Cruz G, Cano MD, Matas-Garcia A, Padrosa J, Tobias-Baraja E, Garrabou G, Aldecoa I, Espinosa G, Simeon-Aznar CP, Guillen-Del-Castillo A, Gil-Vila A, Trallero-Araguás E, Christopher-Stine L, Lloyd TE, Liewluck T, Naddaf E, Stenzel W, Greenberg SA, Grau JM, Selva-O'Callaghan A, Milisenda JC, Mammen AL. Pinal-Fernandez I, et al. Among authors: guillen del castillo a. Ann Rheum Dis. 2024 Oct 21;83(11):1549-1560. doi: 10.1136/ard-2024-225773. Ann Rheum Dis. 2024. PMID: 38902010
Identifying the risk of cancer-associated systemic sclerosis.
Guillen-Del-Castillo A, Simeón-Aznar CP. Guillen-Del-Castillo A, et al. Joint Bone Spine. 2023 Dec;90(6):105618. doi: 10.1016/j.jbspin.2023.105618. Epub 2023 Jul 22. Joint Bone Spine. 2023. PMID: 37482176 No abstract available.
Systemic sclerosis associated myopathy: how to treat.
Selva-O'Callaghan A, Guillen-Del-Castillo A, Gil-Vila A, Trallero-Araguás E, Matas-García A, Milisenda JC, Pinal-Fernández I, Simeón-Aznar C. Selva-O'Callaghan A, et al. Among authors: guillen del castillo a. Curr Treatm Opt Rheumatol. 2023 Dec;9(4):151-167. doi: 10.1007/s40674-023-00206-y. Epub 2023 Jul 19. Curr Treatm Opt Rheumatol. 2023. PMID: 38737329 Free PMC article.
Pathogenic autoantibody internalization in myositis.
Pinal-Fernandez I, Muñoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J, Dell'Orso S, Naz F, Islam S, Gutierrez-Cruz G, Cano MD, Matas-Garcia A, Padrosa J, Tobías-Baraja E, Garrabou G, Aldecoa I, Espinosa G, Simeon-Aznar CP, Guillen-Del-Castillo A, Gil-Vila A, Trallero-Araguas E, Christopher-Stine L, Lloyd TE, Liewluck T, Naddaf E, Stenzel W, Greenberg SA, Grau JM, Selva-O'Callaghan A, Milisenda JC, Mammen AL. Pinal-Fernandez I, et al. Among authors: guillen del castillo a. medRxiv [Preprint]. 2024 Jan 17:2024.01.15.24301339. doi: 10.1101/2024.01.15.24301339. medRxiv. 2024. PMID: 38313303 Free PMC article. Preprint.
Immunoglobulins in systemic sclerosis management. A large multicenter experience.
Tandaipan J, Guillén-Del-Castillo A, Simeón-Aznar CP, Carreira PE, De la Puente C, Narváez J, Lluch J, Rubio-Rivas M, Alegre-Sancho JJ, Bonilla G, Moriano C, Casafont-Sole I, García-Vicuña R, Ortiz-Santamaría V, Riera E, Atienza-Mateo B, Blanco R, Galisteo C, Gonzalez-Martin JJ, Pego-Reigosa JM, Pros A, Heredia S, Castellví I. Tandaipan J, et al. Among authors: guillen del castillo a. Autoimmun Rev. 2023 Nov;22(11):103441. doi: 10.1016/j.autrev.2023.103441. Epub 2023 Sep 12. Autoimmun Rev. 2023. PMID: 37708984 Review.
Novel risk factors related to cancer in scleroderma.
Bernal-Bello D, de Tena JG, Guillén-Del Castillo A, Selva-O'Callaghan A, Callejas-Moraga EL, Marín-Sánchez AM, Fonollosa-Pla V, Simeón-Aznar CP. Bernal-Bello D, et al. Among authors: guillen del castillo a. Autoimmun Rev. 2017 May;16(5):461-468. doi: 10.1016/j.autrev.2017.03.012. Epub 2017 Mar 8. Autoimmun Rev. 2017. PMID: 28285170 Review.
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Deibel E, Carreira PE, Vonk M, Del Papa N, Bečvář R, Guillén-Del-Castillo A, Campochiaro C, Poormoghim H, Liem S, Lazzaroni MG, Giollo A, Mekinian A, de Vries-Bouwstra J, De Santis M, Balbir-Gurman A, Mihai C, De Luca G, Moiseev S, Zanatta E, Foti R, Rednic S, Denton C, Cutolo M, Belloli L, Airo P, Garzanova L, Moroncini G, İnanç M, Panopoulos S, Tandaipan JL, Chatelus E, Rosato E, Kuwana M, Yavuz S, Alegre-Sancho JJ, Smith V, Szűcs G, Henes J, Rodríguez-Pintó I, Atzeni F, Spierings J, Truchetet ME, Milchert M, Brito de Araujo D, Riemekasten G, Bernardino V, Martin T, Del Galdo F, Vacca A, Mendoza F, Midtvedt Ø, Murdaca G, Santiago T, Codullo V, Cacciapaglia F, Walker U, Brunborg C, Tirelli F, Allanore Y, Furst DE, Matucci M, Gabrielli A, Distler O, Hoffmann-Vold AM. Deibel E, et al. Among authors: guillen del castillo a. Arthritis Care Res (Hoboken). 2024 Jan;76(1):88-97. doi: 10.1002/acr.25226. Epub 2023 Dec 11. Arthritis Care Res (Hoboken). 2024. PMID: 37667424 Free article.
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review.
Fritzler MJ, Bentow C, Beretta L, Palterer B, Perurena-Prieto J, Sanz-Martínez MT, Guillen-Del-Castillo A, Marín A, Fonollosa-Pla V, Callejas-Moraga E, Simeón-Aznar CP, Mahler M. Fritzler MJ, et al. Among authors: guillen del castillo a. Diagnostics (Basel). 2023 Mar 27;13(7):1257. doi: 10.3390/diagnostics13071257. Diagnostics (Basel). 2023. PMID: 37046475 Free PMC article. Review.
65 results